Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, settembre 08
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Elevance Health Inc
ELV
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$407.50
-7.28
-1.76%
In chiusura: Sep 4, 5:00 PM EST
$407.50
N/A
Post-mercato: Sep 4, 4:15 PM EST
Get Report
Dividendo:
La data di stacco del dividendo è domani
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Dividendi
Confronta
Opzioni
Rapporto azionario
Elevance Health Financials
Elevance Health (ELV) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings
Elevance Health Inc. (NYSE:ELV) reported strong Q2 results and raised full-year guidance. Analysts have adjusted price targets for ELV stock.
Avi Kapoor
Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a conservative guidance raise.
Vandana Singh
Earnings Scheduled For July 15, 2026
Companies Reporting Before The Bell • VCI Global (NASDAQ:VCIG) is estimated to report earnings for its Fiscal Year 2025. • PNC Financial Services Gr (NYSE:PNC) is projected to report quarterly earnings at $4.43 per
Benzinga Insights
PRO
Elevance Health Sees FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est
Elevance Health (NYSE:ELV) FY2026 EPS expected to be more than $20.10 vs $20.26 Est..
Benzinga Newsdesk
PRO
Elevance Health Sees FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est
Elevance Health (NYSE:ELV) FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est..
Benzinga Newsdesk
PRO
Elevance Health Q2 Adj. EPS $7.45 Beats $6.21 Estimate, Sales $49.826B Beat $48.693B Estimate
Elevance Health (NYSE:ELV) reported quarterly earnings of $7.45 per share which beat the analyst consensus estimate of $6.21 by 19.97 percent. This is a 15.72 percent decrease over earnings of $8.84 per share from the
Benzinga Newsdesk
Privacy Manager